Z-360 was found to inhibit this pain cascade, suggesting that Z-360 reduces cancer-induced pain through the suppression of IL-1β production in cancer-inoculated regions, which in turn inhibits ephrin B1 gene expression, and tyrosine phosphorylation of NR2B. Here, IL1B is linked to cancer.